Creative Biolabs is drawing attention to the limitations of bulk RNA analysis and the need for method selection that aligns with biological questions and sample constraints. The company’s announcement outlines three complementary services—single-cell RNA sequencing (scRNA-seq), single-nucleus RNA sequencing (snRNA-seq), and single-molecule fluorescence in situ hybridization (smFISH)—each suited to different experimental contexts. The move matters because researchers increasingly recognize that rare cell populations, transient cellular states, and cell-to-cell variability can be obscured in bulk samples, and choosing the wrong profiling method can introduce biases or lose critical information.
For studies using viable, dissociated cells, Creative Biolabs’ single-cell RNA sequencing service covers experimental planning, cell isolation, library preparation, sequencing, and data analysis. This approach supports gene-expression analysis across individual cells and can help identify distinct populations and expression signatures in cancer, immunology, and developmental biology. However, tissue dissociation can be problematic: certain cells are difficult to recover intact, and sample handling may alter transcriptional states. For complex tissues such as brain specimens or samples that resist dissociation, the company offers single-nucleus RNA sequencing, which analyzes isolated nuclei and can accommodate suitably preserved frozen tissues while reducing some dissociation-related biases. Sample suitability still depends on preservation method and nuclei quality.
The methods are not interchangeable. Whole-cell and nuclear RNA profiling capture different transcript populations, and tissue preservation, RNA integrity, and research objectives influence the information obtained. Nuclei isolation and transcript capture can also introduce method-specific biases, so early method selection helps align sample preparation with downstream analysis. This distinction is important because it pushes researchers to consider sample type and preservation before committing to a workflow, rather than defaulting to a single approach.
Sequencing can suggest that a gene is enriched in a particular cell population, but some follow-up questions require direct visualization. Creative Biolabs’ single-molecule FISH analysis service uses fluorescently labeled oligonucleotide probes to detect selected RNA molecules in fixed cells, supporting investigation of transcript abundance and subcellular localization. Unlike transcriptome-wide sequencing, conventional smFISH typically examines preselected RNA targets and requires careful probe design, controls, imaging, and image analysis. Its value lies in focused questions—such as whether a transcript is present in particular cells or where it accumulates—rather than replacing broad discovery profiling.
Together, these approaches give researchers different options for studying cellular heterogeneity. A project might use scRNA-seq to characterize accessible cells, switch to snRNA-seq when intact-cell recovery is problematic, or apply smFISH to examine localization of priority transcripts. The implication is that method choice should be driven by sample suitability and the research hypothesis, not convenience. By offering distinct profiling and visualization services, Creative Biolabs supports researchers in selecting approaches suited to their experimental objectives. All services are intended for research use only, not for diagnostic or therapeutic purposes.


